Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Biological Effects of Radiation02:59

Biological Effects of Radiation

All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What is the Impact of Treatment De-Escalation on Patient Reported Outcomes in Patients with T1-T2 Oropharyngeal Cancers? A Secondary Analysis of the ORATOR Studies.

International journal of radiation oncology, biology, physics·2026
Same author

Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomes.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

A Bayesian Causal Model for Matrix-Valued Exposures With Applications to Radiotherapy Planning.

Statistics in medicine·2026
Same author

Refining adjuvant radiation therapy decision using a nomogram in major salivary gland carcinoma.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Clinical Factors and Income Status are Associated with Depression and Anxiety in Head and Neck Cancer Patients.

Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale·2026
Same author

Prognostic Value of Impaired Vocal Cord Mobility in T2N0 Glottic Cancer Treated With IMRT.

The Laryngoscope·2026

Related Experiment Video

Updated: Jun 9, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

The relationship between external beam radiotherapy dose and chronic urinary dysfunction--a methodological critique.

Tara Rosewall1, Charles Catton, Geoffrey Currie

  • 1Princess Margaret Hospital and Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada. Tara.Rosewall@rmp.uhn.on.ca

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|September 7, 2010
PubMed
Summary

Consistent links between external beam radiotherapy dose and chronic urinary dysfunction are lacking due to flawed measurement methods. Improved dose quantification and objective dysfunction metrics are needed for reliable clinical practice.

More Related Videos

Dosimetry for Cell Irradiation using Orthovoltage (40-300 kV) X-Ray Facilities
06:51

Dosimetry for Cell Irradiation using Orthovoltage (40-300 kV) X-Ray Facilities

Published on: February 20, 2021

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Related Experiment Videos

Last Updated: Jun 9, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Dosimetry for Cell Irradiation using Orthovoltage (40-300 kV) X-Ray Facilities
06:51

Dosimetry for Cell Irradiation using Orthovoltage (40-300 kV) X-Ray Facilities

Published on: February 20, 2021

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Area of Science:

  • Radiation Oncology
  • Urology
  • Medical Physics

Background:

  • Chronic urinary dysfunction is a common side effect of radiotherapy.
  • Previous studies show inconsistent associations between radiotherapy dose and urinary dysfunction.

Purpose of the Study:

  • To critique the methodology of studies evaluating radiotherapy dose/volume parameters and chronic urinary dysfunction.
  • To identify reasons for inconsistent findings in the literature.

Main Methods:

  • Literature review of English-language articles (1999-2009) on megavoltage external beam radiotherapy.
  • Methodological critique focusing on dose quantification and dysfunction assessment.

Main Results:

  • Only 9 of 22 studies found a significant dose-dysfunction relationship.
  • Inaccurate dose estimation due to poor surrogate variables and unaddressed positional variations.
  • Subjective and aggregated toxicity metrics obscured precise dysfunction categorization.

Conclusions:

  • A robust evidence base linking radiotherapy dose to chronic urinary dysfunction is currently absent.
  • Accurate dose accumulation and objective dysfunction measures are essential.
  • Improved methodologies will enable reliable clinical practice guidelines.